Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines
- PMID: 1372905
Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines
Abstract
Antibodies elicited by immunization with short peptides containing antigenic determinants have been shown, in general, to bind with greatly reduced affinity to the corresponding region in the native proteins. Thus, contiguous linear peptides have not proven to be effective immunogens in generating high affinity neutralizing or protective antibodies and consequently appear to be poor prospects for vaccines. The molecular basis for such reduced reactivity is clear from the crystal structure determination of antibody Fabs bound to protein antigens, which showed the complementarity between interfaces to be lock-and-key-like and extending over a large area (750 A2) involving discontinuous segments of the polypeptide chain. Thus, small perturbations in the secondary and tertiary structure of the antigen have profound effects on the fit of the antigen and its corresponding antibody. Because short peptides are unlikely to assume any particular conformation in solution, the fit is likely to be poor. New strategies are therefore required to produce conformationally stable peptides that mimic the critical structural features of the protein antigenic site. Here we show that a putative topographic determinant of the testis-specific isozyme of lactate dehydrogenase C4 (LDH-C4), designed and synthesized to adopt a well defined alpha-helical secondary and tertiary structure (four-helix bundle motif) in aqueous solutions, is highly immunogenic in both rabbits and mice, inducing IgG antibodies that bind to native LDH-C4. This engineered conformational 40-residue peptide is considerably more effective in inducing antibodies, as compared with the corresponding linear peptide. The antibody response is obtained without coupling the peptide to a carrier protein, suggesting that the peptide contains a T-cell antigenic determinant. The strategy described here to produce a conformationally stable peptide that mimics the native structure may have general applications in vaccine design.
Similar articles
-
Engineered topographic determinants with alpha beta, beta alpha beta, and beta alpha beta alpha topologies show high affinity binding to native protein antigen (lactate dehydrogenase-C4).J Biol Chem. 1993 Dec 5;268(34):25285-95. J Biol Chem. 1993. PMID: 8244959
-
Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.J Mol Recognit. 1993 Jun;6(2):81-94. doi: 10.1002/jmr.300060206. J Mol Recognit. 1993. PMID: 7508238
-
Immunogenicity of peptides having pre-determined alpha-helical and alpha-alpha fold topologies.Mol Immunol. 1991 Oct;28(10):1047-53. doi: 10.1016/0161-5890(91)90019-g. Mol Immunol. 1991. PMID: 1717836
-
Antigenic sites of lactate dehydrogenase-C4.Isozymes Curr Top Biol Med Res. 1987;14:103-22. Isozymes Curr Top Biol Med Res. 1987. PMID: 2439476 Review.
-
Development of antifertility vaccine using sperm specific proteins.Indian J Med Res. 2014 Nov;140 Suppl(Suppl 1):S73-7. Indian J Med Res. 2014. PMID: 25673547 Free PMC article. Review.
Cited by
-
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.Future Oncol. 2012 Aug;8(8):961-87. doi: 10.2217/fon.12.95. Future Oncol. 2012. PMID: 22894670 Free PMC article. Review.
-
Folded conformations of antigenic peptides from riboflavin carrier protein in aqueous hexafluoroacetone.Protein Sci. 1998 Jan;7(1):123-31. doi: 10.1002/pro.5560070113. Protein Sci. 1998. PMID: 9514267 Free PMC article.
-
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy.Hum Vaccin Immunother. 2015;11(6):1368-86. doi: 10.1080/21645515.2015.1026495. Hum Vaccin Immunother. 2015. PMID: 25874884 Free PMC article. Review.
-
Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.J Biol Chem. 2011 Apr 15;286(15):13612-25. doi: 10.1074/jbc.M110.216812. Epub 2011 Feb 14. J Biol Chem. 2011. PMID: 21321115 Free PMC article.
-
Non-Hormonal Contraception.J Clin Med. 2023 Jul 20;12(14):4791. doi: 10.3390/jcm12144791. J Clin Med. 2023. PMID: 37510905 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous